Wockhardt Limited
HSBC Mutual Fund reduced its stake in Wockhardt from 1.30% to 1.17%, selling 2,20,378 shares. The fund now holds 18,98,940 shares.
A global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals, and topicals for diverse therapeutic applications. Wockhardt operates across multiple segments, serving domestic and international markets with a comprehensive product portfolio spanning conventional pharmaceuticals and advanced biopharmaceutical solutions. The company distinguishes itself through vertically integrated operations and a focus on both established and emerging therapeutic areas.
Indian arm of HSBC Asset Management, the investment arm of HSBC Group with over USD 600 billion in global AUM. Manages over Rs 1 lakh crore in India across equity, debt and hybrid schemes. Previously known for integration of L&T Mutual Fund schemes after acquiring it from L&T Finance in 2022, which significantly expanded the franchise.